<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The interleukin 1beta converting enzyme (ICE) family plays a pivotal role in programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> and has been implicated in <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>During reperfusion after filamentous middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, ICE-like cleavage products and tissue immunoreactive interleukin 1beta (IL-1beta) levels increased in ischemic mouse brain </plain></SENT>
<SENT sid="2" pm="."><plain>Ischemic injury decreased after intracerebroventricular injections of ICE-like <z:chebi fb="0" ids="37670">protease inhibitors</z:chebi>, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (z-VAD.FMK), <z:chebi fb="9" ids="46887">acetyl</z:chebi>-Tyr-Val-Ala-Asp-chloromethylketone, or a relatively selective inhibitor of CPP32-like caspases, N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone, but not a cathepsin B inhibitor, N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone </plain></SENT>
<SENT sid="3" pm="."><plain>z-VAD.FMK decreased ICE-like cleavage products and tissue immunoreactive IL-1beta levels in ischemic mouse brain and reduced tissue damage when administered to rats as well </plain></SENT>
<SENT sid="4" pm="."><plain>Only z-VAD.FMK and <z:chebi fb="9" ids="46887">acetyl</z:chebi>-Tyr-Val-Ala-Asp-chloromethylketone reduced <z:e sem="disease" ids="C1527311" disease_type="Disease or Syndrome" abbrv="">brain swelling</z:e>, and N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketone did not attenuate the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in tissue IL-1beta levels </plain></SENT>
<SENT sid="5" pm="."><plain>The three cysteine <z:chebi fb="0" ids="37670">protease inhibitors</z:chebi> significantly improved behavioral deficits, thereby showing that functional recovery of ischemic neuronal tissue can follow blockade of enzymes associated with apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, we examined the effect of z-VAD.FMK on excitotoxicity and found that it protected against alpha-amino-3-hydroxy-5-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-<z:chebi fb="0" ids="35595">isoxazole</z:chebi> <z:chebi fb="0" ids="17272">propionate</z:chebi>-induced or to a lesser extent <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi>-induced excitotoxic brain damage </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, ICE-like and CPP32-like caspases contribute to mechanisms of cell <z:hpo ids='HP_0011420'>death</z:hpo> in ischemic and excitotoxic brain injury and provide therapeutic targets for <z:hpo ids='HP_0001297'>stroke</z:hpo> and neurodegenerative brain damage </plain></SENT>
</text></document>